Zobrazeno 1 - 10
of 16
pro vyhledávání: '"Adri KOK"'
Autor:
Hemant Makan, Lindie Makan, Jacqueline Lubbe, Sarah Alami, Guila Lancman, Manuella Schaller, Cécile Delval, Adri Kok
Publikováno v:
JMIR Formative Research, Vol 7, p e35790 (2023)
BackgroundIn South Africa, diabetes prevalence is expected to reach 5.4 million by 2030. In South Africa, diabetes-related complications severely impact not only patient health and quality of life but also the economy. ObjectiveThe Diabetes Nurse Ed
Externí odkaz:
https://doaj.org/article/25e35fec3b1b44e6a7e02baf2f433c67
Autor:
Khadija Hafidh, Rachid Malek, Khalid Al-Rubeaan, Adri Kok, Fahri Bayram, Akram Echtay, Viraj Rajadhyaksha, Ahmed Hadaoui
Publikováno v:
Frontiers in Endocrinology, Vol 13 (2022)
BackgroundWe evaluated the prevalence of vascular complications and associated risk factors in individuals with type 2 diabetes mellitus (T2DM) initiating second-line glucose-lowering therapy from the Middle East and Africa (MEA) cohort of the 3-year
Externí odkaz:
https://doaj.org/article/7cba735a76f7445abc964d9be0104d6f
Autor:
Adri Kok, Hemant Makan, Gracjan Piotr Podgorski, Shaifali Joshi, Verushka Chetty, Lungisa Nojoko, Hajira Bacus, Naeem Moosa, Duma Khutsoane
Publikováno v:
Journal of Endocrinology, Metabolism and Diabetes of South Africa. :1-8
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::575e7601fc22be53f23a6b3bbc20556e
https://doi.org/10.1080/16089677.2023.2198348
https://doi.org/10.1080/16089677.2023.2198348
Autor:
Charles Feldman, Sipho Dlamini, Guy A. Richards, John Black, India L. C. Butler, Clare Cutland, Eric Hefer, Bridget Hodkinson, Adri Kok, Pravin Manga, Susan Meiring, Muhangwi Molaudzi, Mahomed-Yunus S. Moosa, Salim Parker, Jonny Peter, Cloete van Vuuren, Estelle Verburgh, Gill Watermeyer
Publikováno v:
Journal of Thoracic Disease. 14:4150-4172
Pneumococcal infections remain a common global cause of significant morbidity and mortality. The first recommendations for adult pneumococcal vaccination, published in South Africa in 1999, contained information only on the 23-valent polysaccharide v
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3b2a78e2dcfc57ecf1cb9426892244f4
https://doi.org/10.21037/jtd-22-287
https://doi.org/10.21037/jtd-22-287
Autor:
Gregory R. Fulcher, Shahid Akhtar, Saleh J. Al-Jaser, Johan Medina, Mafauzy Mohamed, Nemencio A. Nicodemus, Anne Helene Olsen, Kiran P. Singh, Adri Kok
Publikováno v:
Advances in Therapy. 39:3735-3748
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::c5587ad386ba460dda9056d0c3a59d0a
https://doi.org/10.1007/s12325-022-02212-3
https://doi.org/10.1007/s12325-022-02212-3
Autor:
Mafauzy Mohamed, Saleh Jaser Al-Jaser, Gregory R. Fulcher, Kiran Pal Singh, Henrik Jarlov, Johanne Spanggaard Piltoft, Adri Kok, Nemencio Almare Nicodemus, Lei Liu
Publikováno v:
Endocrine
PURPOSE IDegAsp, a co-formulation of long-acting basal (insulin degludec) and rapid-acting bolus (insulin aspart) insulin, provides separate prandial and basal glucose-lowering effects with relatively low risk of hypoglycaemia. Its efficacy and safet
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::115d8f9d8b2f7461c027b9e0416112d5
https://doi.org/10.1007/s12020-021-02887-8
https://doi.org/10.1007/s12020-021-02887-8
Autor:
Khalid Al-Rubeaan, Mohamed Alsayed, Abdullah Ben-Nakhi, Fahri Bayram, Akram Echtay, Ahmed Hadaoui, Khadija Hafidh, Kevin Kennedy, Adri Kok, Rachid Malek, Viraj Rajadhyaksha, Suzanne V. Arnold
© 2022, The Author(s).Introduction: Despite the high prevalence of type 2 diabetes (T2D) and suboptimal glycemic control in the Middle East and Africa, comprehensive data on the management of T2D remain scarce. The main aim of this study is to descr
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::131d471763bfbde1b54123bb4bf16c2e
https://avesis.kayseri.edu.tr/publication/details/8442d0cd-8361-4103-8b43-4f4c7e8fc2e9/oai
https://avesis.kayseri.edu.tr/publication/details/8442d0cd-8361-4103-8b43-4f4c7e8fc2e9/oai
Autor:
Gregory R. Fulcher, Shahid Akhtar, Saleh J. Al-Jaser, Johan Medina, Mafauzy Mohamed, Nemencio A. Nicodemus, Anne Helene Olsen, Kiran P. Singh, Adri Kok
Publikováno v:
Advances in Therapy. 40:389-390
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::176b0e2e952dc57f66a7332128cfbedf
https://doi.org/10.1007/s12325-022-02349-1
https://doi.org/10.1007/s12325-022-02349-1
Autor:
Takahisa Hirose, Adri Kok, Roger Lehmann, Roger Chen, Gregory R. Fulcher, Ambika Gopalakrishnan Unnikrishnan, Roopa Mehta, Dilek Gogas Yavuz, Mathew John
Publikováno v:
Diabetes, Obesity & Metabolism
Insulin degludec/insulin aspart (IDegAsp) is a fixed‐ratio co‐formulation of insulin degludec, which provides long‐lasting basal insulin coverage, and insulin aspart, which targets postprandial glycaemia. This review provides expert opinion on
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::95d4e545752d45022842f687811271f9
https://doi.org/10.1111/dom.14128
https://doi.org/10.1111/dom.14128